Predict your next investment

Corporation
HEALTHCARE | Medical Equipment & Supplies
genescan-europe.com

See what CB Insights has to offer

Stage

Asset Sale

Total Raised

$6.69M

Investors Count

2

Portfolio Exits

1

Investments

1

GeneScan Europe Funding, GeneScan Europe Valuation & GeneScan Europe Revenue

4 Fundings

GeneScan Europe's latest funding round was a IPO for $68.29M on July 21, 2000.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

7/21/2000

IPO

$68.29M

$0.00B

((9.99x))

FY 1234

1

3/28/2000

Mezzanine

$99M

$0.00B

((9.99x))

FY 1234

10

10/28/1999

Series A

$99M

$0.00B

((9.99x))

FY 1234

10

1/14/1999

Seed

$99M

$0.00B

((9.99x))

FY 1234

10

Date

7/21/2000

3/28/2000

10/28/1999

1/14/1999

Round

IPO

Mezzanine

Series A

Seed

Amount

$68.29M

$99M

$99M

$99M

Investors

Valuation

Revenue

$0.00B

((9.99x))

FY 1234

$0.00B

((9.99x))

FY 1234

$0.00B

((9.99x))

FY 1234

$0.00B

((9.99x))

FY 1234

Sources

1

10

10

10

GeneScan Europe Investors

2 Investors

GeneScan Europe has 2 investors. Vestcorp AG invested in GeneScan Europe's Mezzanine funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

1/14/1999

3/28/2000

2
Seed, Mezzanine (2000)

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Private Equity

United Kingdom

First funding

1/14/1999

00/00/0000

Last Funding

3/28/2000

00/00/0000

Investor

Subscribe to see more

Rounds

2
Seed, Mezzanine (2000)

Subscribe to see more

Board Seats

Subscribe to see more

Type

Private Equity

Location

United Kingdom

GeneScan Europe Investments

1 Investments

GeneScan Europe has made 1 investments. Their latest investment was in Oasis Biosciences as part of their Corporate Minority on March 3, 2001.

CBI Logo

GeneScan Europe Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

3/1/2001

Corporate Minority

Oasis Biosciences

$7M

Yes

1

Date

3/1/2001

Round

Corporate Minority

Company

Oasis Biosciences

Amount

$7M

New?

Yes

Co-Investors

Sources

1

GeneScan Europe Portfolio Exits

1 Portfolio Exit

GeneScan Europe has 1 portfolio exit. Their latest portfolio exit was Oasis Biosciences on December 23, 2003.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

12/23/2003

Asset Sale

Undisclosed Investors

1

Date

12/23/2003

Exit

Asset Sale

Companies

Valuation

Acquirer

Undisclosed Investors

Sources

1

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.